Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00571194 · ClinicalTrials.gov registry record · Phase 1
Single Dose Pravastatin Pharmacokinetics in Pediatric Peritoneal Dialysis Patients
A Phase 1 study, sponsored by Arkansas Children's Hospital Research Institute.
- Terminated
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT00571194: Clinical Trial Phase 1 study, sponsored by Arkansas Children's Hospital Research Institute.
NCT00571194 is a Phase 1 study that was terminated before completion, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 7 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00571194, a Phase 1 study, was terminated before completion, sponsored by Arkansas Children's Hospital Research Institute.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
Many children with end stage renal disease develop hyperlipidemia. HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase inhibitors, such as pravastatin, are typical treatments for hyperlipidemia. However, we do not know how pravastatin is metabolized in patients on dialysis. This study is designed to provide preliminary pharmacokinetic data for pravastatin in pediatric patients on peritoneal dialysis.
Interventions
- DRUG pravastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2007-09 |
| Est. Completion | 2009-05 |
| Phase | Phase 1 |
Why NCT00571194 stopped before completion
NCT00571194 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which pravastatin is the first listed.
NCT00571194 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00571194 about?
NCT00571194 is a clinical study titled "Single Dose Pravastatin Pharmacokinetics in Pediatric Peritoneal Dialysis Patients". Many children with end stage renal disease develop hyperlipidemia. HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase inhibitors, such as pravastatin, are typical treatments for hyperlipidemia. However, we do not know how pravastatin is metabolized in patients on dialysis. This study is desig...
What is the current status of trial NCT00571194?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2007-09. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00571194?
The interventions under investigation include: pravastatin (DRUG).
Who is sponsoring clinical trial NCT00571194?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00571194's enrollment target sits among peer trials
7 1972nd of 2000 higher than 27 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia